ROYCE & ASSOCIATES LP

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 906304 New York, NY

Position in MRVI

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$5,117,907

-$427,077 QoQ

Shares Held

1,808,448

+6.0% QoQ

Ownership

0.700%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $280,717,366 across 29 Biotechnology names. MRVI ranks #18 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	2,089,906	$51,746,072
2	TECH	BIO-TECHNE Corp	759,712	$39,702,549
3	INVA	Innoviva, Inc.	1,061,448	$24,731,738
4	BBIO	BridgeBio Pharma, Inc.	232,923	$17,296,861
5	AXSM	Axsome Therapeutics, Inc.	94,017	$15,890,753
6	ORIC	Oric Pharmaceuticals, Inc.	1,207,223	$15,295,515
7	CRMD	CorMedix Inc.	1,887,532	$12,816,342
8	CNTA	Centessa Pharmaceuticals plc	278,064	$11,044,702

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,117,907	1,808,448	+6.0%	Shares	Sole	2026-05-12
2025-12-31	$5,544,984	1,706,149	-3.2%	Shares	Sole	2026-02-09
2025-09-30	$5,056,262	1,761,764	+38.0%	Shares	Sole	2025-11-12
2025-06-30	$3,077,222	1,276,856	-3.9%	Shares	Sole	2025-08-11
2025-03-31	$2,935,861	1,328,444	+38.5%	Shares	Sole	2025-05-06
2024-12-31	$5,225,923	958,885	+5.5%	Shares	Sole	2025-02-10
2024-09-30	$7,551,945	908,778	+130.4%	Shares	Sole	2024-11-06
2024-06-30	$2,824,233	394,446	+2299.7%	Shares	Sole	2024-08-13
2024-03-31	$142,508	16,437	-69.6%	Shares	Sole	2024-05-13
2022-12-31	$774,256	54,106	-88.2%	Shares	Sole	2023-05-23
2022-06-30	$13,034,167	458,788	+31.3%	Shares	Sole	2022-08-04
2022-03-31	$12,326,335	349,485	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.